We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Xenomics Announces License with Asuragen for NPM1 Leukemia Diagnostics

Asuragen gains right to develop, manufacture and market products for the diagnosis, stratification and monitoring of patients with AML.
News

Quest Diagnostics Licenses Technology Underlying SensiTrop™ HIV Co-Receptor Tropism Test from Pathway Diagnostics

Quest Diagnostics licenses the heteroduplex tracking technology underlying Pathway's SensiTrop™ HIV co-receptor tropism test.
News

Novel Alternative Approach to Inhibiting Insulin Growth Factor may provide new Treatment for Breast Cancer and Other Cancers

Potential to halt cancer cell growth without interfering with insulin may address limitations of current IGF inhibitors.
News

Vermillion Completes Clinical Trial Enrollment for Ovarian Cancer Triage Test

The clinical trial was designed to demonstrate that the ovarian triage test is a useful adjunct for distinguishing benign from malignant ovarian tumors.
News

Premier Inc. Adds Roche HIV-1 Test to Existing Contract

Premier gave its 1,700 hospital members access in August to the Roche COBAS® Ampliprep/COBAS® TaqMan® HIV-1 assay.
News

National Cancer Institute Awards $1.1 Million SBIR Contract to Rules-Based Medicine

The fund will develop 50 new quantitative, multiplexed immunoassays for cancer-related proteins to be added to the automated RBM HumanMAP® platform.
News

C-Path and Ventana Medical Systems to Collaborate on Developing Standardized Evaluation for Companion Diagnostic Tests and Targeted Cancer Therapies

C-Path has received a $2.1 million grant from Science Foundation Arizona to fund a collaboration project with the US FDA and the National Cancer Institute.
News

Enigma Diagnostics Announces a European Commission Award of EUR3 Million

The award will fund the development of a point of care platform for the rapid diagnosis of influenza infections.
News

GE and Lilly Collaborates to Co-Develop Molecular In-Vitro Diagnostics for Cancer Treatments

The collaboration is focused on developing diagnostic tools to predict patients’ response to targeted therapies.
News

New Nordic EMBL Partnership for Molecular Medicine

EMBL has partnered with Universities of Finland, Oslo and Umea to explore molecularly and genetically based treatments.
Advertisement